Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

Transfemoral implantation of the ACURATE neo prosthesis using a low-profile expandable introducer system: A multicenter registry.

Kim WK, Brinkert M, Mangner N, Gatto F, Husser O, Renker M, Liebetrau C, Gasior T, Doss M, Walther T, Hamm C, Linke A, Toggweiler S, Möllmann H.

Int J Cardiol. 2019 Jan 25. pii: S0167-5273(18)34810-1. doi: 10.1016/j.ijcard.2019.01.081. [Epub ahead of print]

PMID:
30711266
2.

Assessing the level of radiation experienced by anesthesiologists during transfemoral Transcatheter Aortic Valve Implantation and protection by a lead cap.

Mayr NP, Wiesner G, Kretschmer A, Brönner J, Hoedlmoser H, Husser O, Kasel AM, Lange R, Tassani-Prell P.

PLoS One. 2019 Jan 30;14(1):e0210872. doi: 10.1371/journal.pone.0210872. eCollection 2019.

3.

Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation.

Rheude T, Pellegrini C, Núñez J, Joner M, Trenkwalder T, Mayr NP, Holdenrieder S, Bodi V, Koenig W, Kasel AM, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Rev Esp Cardiol (Engl Ed). 2018 Oct 25. pii: S1885-5857(18)30390-6. doi: 10.1016/j.rec.2018.09.006. [Epub ahead of print] English, Spanish.

PMID:
30482731
4.

Effects of the coronary artery disease associated LPA and 9p21 loci on risk of aortic valve stenosis.

Trenkwalder T, Nelson CP, Musameh MD, Mordi IR, Kessler T, Pellegrini C, Debiec R, Rheude T, Lazovic V, Zeng L, Martinsson A, Gustav Smith J, Gådin JR, Franco-Cereceda A, Eriksson P, Nielsen JB, Graham SE, Willer CJ, Hveem K, Kastrati A, Braund PS, Palmer CNA, Aracil A, Husser O, Koenig W, Schunkert H, Lang CC, Hengstenberg C, Samani NJ.

Int J Cardiol. 2019 Feb 1;276:212-217. doi: 10.1016/j.ijcard.2018.11.094. Epub 2018 Nov 17.

PMID:
30482443
5.

Characterization and implications of the dynamics of eosinophils in blood and in the infarcted myocardium after coronary reperfusion.

Rios-Navarro C, Gavara J, Vidal V, Bonanad C, Racugno P, Bayes-Genis A, Miñana G, Husser O, Oltra R, Nuñez J, Chorro FJ, Bodi V, Ruiz-Sauri A.

PLoS One. 2018 Oct 26;13(10):e0206344. doi: 10.1371/journal.pone.0206344. eCollection 2018.

6.

Critical adverse events during transfemoral TAVR in conscious sedation. Is an anesthesiologic support mandatory?

Mayr NP, Wiesner G, Husser O, Joner M, Michel J, Knorr J, Pellegrini C, Bleiziffer S, Schunkert H, Lange R, Tassani-Prell P.

Cardiovasc Revasc Med. 2018 Sep;19(6S):41-46. doi: 10.1016/j.carrev.2018.06.014. Epub 2018 Jun 21.

PMID:
30327095
7.

Spotlight on the SAPIEN 3 transcatheter heart valve.

Rheude T, Blumenstein J, Möllmann H, Husser O.

Med Devices (Auckl). 2018 Oct 1;11:353-360. doi: 10.2147/MDER.S143897. eCollection 2018. Review.

8.

Prophylactic ECMO during TAVI in patients with depressed left ventricular ejection fraction.

Trenkwalder T, Pellegrini C, Holzamer A, Rheude T, Riester J, Reinhard W, Mayr NP, Kasel AM, Gaede L, Blumenstein J, Kastrati A, Schunkert H, Joner M, Hilker M, Hengstenberg C, Husser O.

Clin Res Cardiol. 2018 Aug 28. doi: 10.1007/s00392-018-1364-6. [Epub ahead of print]

PMID:
30155732
9.

Multicenter Evaluation of Prosthesis Oversizing of the SAPIEN 3 Transcatheter Heart Valve. Impact on Device Failure and New Pacemaker Implantations.

Pellegrini C, Kim WK, Holzamer A, Walther T, Mayr NP, Michel J, Rheude T, Nuñez J, Kasel AM, Trenkwalder T, Kaess BM, Joner M, Kastrati A, Schunkert H, Hilker M, Möllmann H, Hengstenberg C, Husser O.

Rev Esp Cardiol (Engl Ed). 2018 Jul 14. pii: S1885-5857(18)30239-1. doi: 10.1016/j.rec.2018.06.005. [Epub ahead of print] English, Spanish.

PMID:
30017841
10.

Conscious Sedation Versus General Anesthesia in Transcatheter Aortic Valve Replacement: The German Aortic Valve Registry.

Husser O, Fujita B, Hengstenberg C, Frerker C, Beckmann A, Möllmann H, Walther T, Bekeredjian R, Böhm M, Pellegrini C, Bleiziffer S, Lange R, Mohr F, Hamm CW, Bauer T, Ensminger S; GARY Executive Board.

JACC Cardiovasc Interv. 2018 Mar 26;11(6):567-578. doi: 10.1016/j.jcin.2017.12.019.

PMID:
29566803
11.

Predictors of Need for Permanent Pacemaker Implantation and Conduction Abnormalities With a Novel Self-expanding Transcatheter Heart Valve.

Pellegrini C, Husser O, Kim WK, Holzamer A, Walther T, Rheude T, Mayr NP, Trenkwalder T, Joner M, Michel J, Chaustre F, Kastrati A, Schunkert H, Burgdorf C, Hilker M, Möllmann H, Hengstenberg C.

Rev Esp Cardiol (Engl Ed). 2019 Feb;72(2):145-153. doi: 10.1016/j.rec.2018.01.011. Epub 2018 Mar 16. English, Spanish.

PMID:
29551701
12.

Incidental findings in multislice computed tomography prior to transcatheter aortic valve implantation: frequency, clinical relevance and outcome.

Trenkwalder T, Lahmann AL, Nowicka M, Pellegrini C, Rheude T, Mayr NP, Voss S, Bleiziffer S, Lange R, Joner M, Kasel AM, Kastrati A, Schunkert H, Husser O, Hadamitzky M, Hengstenberg C.

Int J Cardiovasc Imaging. 2018 Jun;34(6):985-992. doi: 10.1007/s10554-018-1305-5. Epub 2018 Feb 21.

PMID:
29468355
13.

Dexmedetomidine versus propofol-opioid for sedation in transcatheter aortic valve implantation patients: a retrospective analysis of periprocedural gas exchange and hemodynamic support.

Mayr NP, Wiesner G, van der Starre P, Hapfelmeier A, Goppel G, Kasel AM, Hengstenberg C, Husser O, Schunkert H, Tassani-Prell P.

Can J Anaesth. 2018 Jun;65(6):647-657. doi: 10.1007/s12630-018-1092-4. Epub 2018 Feb 20.

PMID:
29464420
14.

Computed Tomography for Diagnosis and Classification of Bicuspid Aortic Valve Disease in Transcatheter Aortic Valve Replacement.

Kim WK, Gaede L, Husser O, Liebetrau C, Renker M, Rolf A, Fischer-Rasokat U, Möllmann S, Blumenstein J, Guenther E, Van Linden A, Arsalan M, Doss M, Loders S, Arnold M, Hamm CW, Walther T, Achenbach S, Möllmann H.

JACC Cardiovasc Imaging. 2018 Oct;11(10):1539-1540. doi: 10.1016/j.jcmg.2017.12.010. Epub 2018 Feb 14. No abstract available.

PMID:
29454778
15.

Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation.

Rheude T, Pellegrini C, Schmid H, Trenkwalder T, Mayr NP, Joner M, Kasel AM, Holdenrieder S, Nunez J, Sanchis J, Bodi V, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Am J Cardiol. 2018 Feb 15;121(4):461-468. doi: 10.1016/j.amjcard.2017.11.020. Epub 2017 Nov 27.

PMID:
29306485
16.

Determinants of elevated carbohydrate antigen 125 in patients with severe symptomatic aortic valve stenosis referred for transcatheter aortic valve implantation.

Rheude T, Pellegrini C, Reinhard W, Trenkwalder T, Koenig W, Mayr NP, Joner M, Núñez J, Holdenrieder S, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Biomarkers. 2018 May;23(3):299-304. doi: 10.1080/1354750X.2018.1423706. Epub 2018 Jan 15.

PMID:
29297708
17.

A new hope - low permanent pacemaker rates with selfexpanding transcatheter heart valves.

Hengstenberg C, Husser O.

EuroIntervention. 2017 Dec 20;13(11):1255-1257. doi: 10.4244/EIJV13I11A196. No abstract available.

18.

Outcome after transvascular transcatheter aortic valve implantation in 2016.

Gaede L, Blumenstein J, Liebetrau C, Dörr O, Kim WK, Nef H, Husser O, Elsässer A, Hamm CW, Möllmann H.

Eur Heart J. 2018 Feb 21;39(8):667-675. doi: 10.1093/eurheartj/ehx688.

19.

The Lotus dilemma-respond to paravalvular leakage, but not answering pacemaker implantations?

Pellegrini C, Hengstenberg C, Husser O.

J Thorac Dis. 2017 Sep;9(9):2804-2807. doi: 10.21037/jtd.2017.08.64. No abstract available.

20.

Emergency extracorporeal membrane oxygenation in transcatheter aortic valve implantation: A two-center experience of incidence, outcome and temporal trends from 2010 to 2015.

Trenkwalder T, Pellegrini C, Holzamer A, Philipp A, Rheude T, Michel J, Reinhard W, Joner M, Kasel AM, Kastrati A, Schunkert H, Endemann D, Debl K, Mayr NP, Hilker M, Hengstenberg C, Husser O.

Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27385. [Epub ahead of print]

PMID:
29130616

Supplemental Content

Loading ...
Support Center